Jiangsu Hengrui Medicine
600276.SS
#454
Rank
โ‚น3.641 T
Marketcap
โ‚น570.93
Share price
-0.25%
Change (1 day)
10.30%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Earnings for Jiangsu Hengrui Medicine (600276.SS)

Earnings in 2024 (TTM): โ‚น83.64 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current earnings are โ‚น3.88 Billion. , an increase over its 2023 earnings that were of โ‚น56.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jiangsu Hengrui Medicine from 2002 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น85.55 B50.69%
2023 โ‚น56.77 B11.4%
2022 โ‚น50.96 B-13.65%
2021 โ‚น59.02 B-34.21%
2020 โ‚น89.71 B15.95%
2019 โ‚น77.37 B33.03%
2018 โ‚น58.16 B20.89%
2017 โ‚น48.11 B23.89%
2016 โ‚น38.83 B11.21%
2015 โ‚น34.92 B39.5%
2014 โ‚น25.03 B20.61%
2013 โ‚น20.75 B11.46%
2012 โ‚น18.62 B29.7%
2011 โ‚น14.35 B31.16%
2010 โ‚น10.94 B27.92%
2009 โ‚น8.55 B5.8%
2008 โ‚น8.08 B79.95%
2007 โ‚น4.49 B32.89%
2006 โ‚น3.38 B38.19%
2005 โ‚น2.44 B21.56%
2004 โ‚น2.01 B13.95%
2003 โ‚น1.76 B38.06%
2002 โ‚น1.28 B